







Over the last thirteen years, bioRxiv and medRxiv have grown into widely used infrastructure for rapid research sharing in biology and medicine. The reliability and researcher-first values that have defined these platforms since their founding remain central to how we operate, and building on the trust, partnerships, and community relationships researchers worldwide depend on is…
Homepage - openRxiv
openRxiv is an independent non-profit, the new organizational home for bioRxiv and medRxiv, enabling researchers to instantly share groundbreaking findings with the global scientific community.
Introducing Hypothesis commenting on bioRxiv and medRxiv: an updated way to engage with preprints - openRxiv
An important part of our mission at openRxiv is to collaborate with other organizations to improve science communication and promote interoperability. Preprints are just one part of the research workflow, and we want to ensure they are effectively integrated with the tools and communities that drive scientific progress. Today, we’re excited to share about another…
The Story behind the Science: Preprints of pandemic potential—how bioRxiv and medRxiv brought preprints to the life sciences
ABSTRACT The bioRxiv and medRxiv preprint servers brought preprinting to the life sciences and played a critical role in disseminating COVID research during the pandemic. Here, I reflect on the birth of bioRxiv and medRxiv and the crucial role so many members of the community played, our experience during the pandemic, and the launch of the new non-profit organization set up to oversee the servers. The pandemic was a stress test for bioRxiv and medRxiv that demonstrated their value and robustness. Under the umbrella of openRxiv, they are now poised to become long-term infrastructure underpinning a new publishing ecosystem.

Frontiers in Open Science
Curvenote Reader brings a better reading experience to half a million openRxiv preprints
Curvenote Reader is now live across half a million bioRxiv preprints - bringing inline citations, zoomable figures, and connected context directly into the reading flow. Find out how we modernized one of science's biggest preprint repositories without disrupting a single workflow.
Open Social Network Cookbook
The Open Social Network Cookbook is the collective product of the Open Social Incubator, a cohort that MEDLab hosted from Fall 2024 to Spring 2025. At the heart of our work together was the question: How can the online communities that we participate in use tools that truly reflect our values?

OpenRxiv & Curvenote’s new Reader launch took to the stage at FORCE11 2026
At FORCE11 2026, Curvenote showcased the newly launched Curvenote Reader deployed over all of openRxiv to enthusiastic feedback from scientific publishing leaders — with callouts on the innovation from the opening and closing keynotes as a meaningful step forward for open science.
Center for Open Science
At the Center for Open Science, our mission is to increase openness, integrity, and reproducibility of scholarly research. Promoting these practices within the research funding and publishing communities accelerates scientific progress

A Research Lab for Open Source ✸ Software Stewardship Lab
Today, we're launching a world-class research lab dedicated to Open Source sustainability with a team of some of the most experienced people in the world.

Empowering science communities with open, democratic, researcher-owned infrastructure.
We’re building communities and tech for publishing, curating, sharing, and discussing research online using ATProto and other decentralized protocols.

Empowering science communities with open, democratic, researcher-owned infrastructure.
We’re building communities and tech for publishing, curating, sharing, and discussing research online using ATProto and other decentralized protocols.

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change… | Samuel G. Rodriques | 491 comments
We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change that. Kosmos is now the first agent that can compress months of drug development into weeks, from the earliest stages of scientific discovery through to FDA approval. Incyte will be the first company to deploy it across their pipeline. Work that used to take a team of scientists months now happens in weeks. Patients can't wait, and neither can we. | 491 comments on LinkedIn
Researchers | alphaXiv
Browse researcher profiles on alphaXiv: publications, citation metrics, research areas, and the papers behind them.

Who Will Keep Research Data Infrastructure Open and Running?
The scientific community must consider the longevity of open research infrastructure—why it might fail and how to prevent it.

Who Will Keep Research Data Infrastructure Open and Running?
The scientific community must consider the longevity of open research infrastructure—why it might fail and how to prevent it.

Today we're launching the Open Source for Science Fund, a new multi-donor philanthropic fund by Renaissance Philanthropy, seeded by @biohub.org and @wellcometrust.bsky.social, with support from @kavlifoundation.org and @researchsoftware.bsky.social 🧵 os4science.org/news/open-source-for-science-…
Open Source for Science Fund Launches to Power AI-Driven Discovery
os4science.org